ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hyperglycemia"

  • 2021 American Transplant Congress

    Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients

    D. D. de Lucena, I. A. de Brito, M. P. Cristelli, J. O. Medina-Pestana, H. Tedesco-Silva, É. B. Rangel

    Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil

    *Purpose: A high number of comorbidities associated with the severity of the disease caused by SARS-CoV-2 (COVID-19) has been reported, such as systemic arterial hypertension…
  • 2021 American Transplant Congress

    Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant

    A. Petrosan, A. Santeusanio, R. Khaim, V. Delaney

    Mount Sinai Hospital, New York, NY

    *Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…
  • 2021 American Transplant Congress

    The Impact of Diabetes on Young Transplant Recipients: An American Perspective

    J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana

    Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…
  • 2020 American Transplant Congress

    Early Worsening of Diabetic Retinopathy after Pancreas and Kidney Transplantation: Myth or Reality?

    F. Saudek1, B. Voglová1, K. Kesslerová2, T. Sosna2, K. Lipár3

    1Diabetes Center, Institute for Clinical and Experimental Medicine, Praha 4, Czech Republic, 2Ophthalmology, Thomayer Hospital, Praha 4, Czech Republic, 3Transplant Center, Institute for Clinical and Experimental Medicine, Praha 4, Czech Republic

    *Purpose: Type-1 diabetic pancreas and kidney transplant candidates frequently suffer from advanced diabetic retinopathy. Early worsening of diabetic retinopathy (EWDR) attributed to sudden glucose normalization…
  • 2020 American Transplant Congress

    HLA Cw12 in Kidney Transplant Recipients is a Novel Risk Factor for the Development of Post-Transplantation Diabetes: A Single-Centre Retrospective Study

    N. Phagura1, A. Culliford2, F. Evison3, S. Gallier3, J. Nath2, D. Briggs4, A. Sharif2

    1College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 2Department of Nephrology and Transplantation, University Hospitals Birmingham, Birmingham, United Kingdom, 3Department of Health Informatics, University Hospitals Birmingham, Birmingham, United Kingdom, 4H&I Birmingham, NHS Blood and Transplant, Birmingham, Birmingham, United Kingdom

    *Purpose: Counselling kidney transplant candidates for their personalised risk of developing post-transplantation diabetes mellitus (PTDM) requires an understanding of risk factors. While some risk factors…
  • 2020 American Transplant Congress

    Functional Changes in Metabolic and Malignancy Associated Bacterial Genes in the Post Transplant Intestinal Microbiome

    M. Bhat1, S. Sivaraj1, E. Pasini1, J. Copeland2, J. Allard3, A. Humar1

    1Multi-Organ Transplant, UHN, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3UHN, Toronto, ON, Canada

    *Purpose: Long-term survival of liver transplant (LT) recipients is affected by metabolic and malignant complications. The aim of our study was to examine changes in…
  • 2020 American Transplant Congress

    Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?

    K. Croome, D. Livingston, C. Taner, R. Nakhleh

    Mayo Clinic Jacksonville, Jacksonville, FL

    *Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the…
  • 2020 American Transplant Congress

    Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population

    M. Norris1, J. Trofe-Clark1, C. Sammons1, N. Casciello1, S. Cardillo2, D. Sawinski3, R. D. Bloom3, G. Malat1

    1Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, 2Endocrine Div, Univ of Pennsylvania, Philadelphia, PA, 3Renal Div, Univ of Pennsylvania, Philadelphia, PA

    *Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…
  • 2020 American Transplant Congress

    GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity

    M. Stumpf, S. A. Dar, S. Rao, A. Doyle

    University of Virginia, Charlottesville, VA

    *Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…
  • 2020 American Transplant Congress

    Diabetes Burnout: An Under-Recognized Risk-Factor in Post-Transplant Care Management

    N. Pilch, P. Baliga, V. Rao, V. Rohan, K. Foster, H. Perkins, N. Patel, D. Dubay, D. Taber

    Medical University of South Carolina, Charleston, SC

    *Purpose: One-third of dialysis patients will have spontaneous glycemic control improvement, necessitating discontinuation of antihyperglycemic therapy, termed diabetes burnout. The aim of this study was…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences